These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7939780

  • 1. Immunosuppression of patients with acquired factor VIII inhibitors.
    Green D.
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS, Favaloro E, Koutts J.
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract] [Full Text] [Related]

  • 3. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J, de Wit M, Fiedler W, Marx G, Hossfeld DK.
    Schweiz Med Wochenschr; 1996 Nov 23; 126(47):2026-31. PubMed ID: 8984611
    [Abstract] [Full Text] [Related]

  • 4. [Successful cyclosporin therapy of acquired hemophilia caused by factor VIII (VIII:C) inhibiting antibody].
    Pfliegler G, Boda Z, Hársfalvi J, Flóra-Nagy M, Sári B, Pecze K, Rák K.
    Orv Hetil; 1991 Jul 07; 132(27):1485-8. PubMed ID: 1956679
    [Abstract] [Full Text] [Related]

  • 5. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM, Hedner U, Holmberg L.
    Acta Med Scand; 1974 Jul 07; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM, Ludlam CA.
    Semin Hematol; 1993 Apr 07; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract] [Full Text] [Related]

  • 7. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ, Fenske TS, Blinder MA.
    Haemophilia; 2007 Jan 07; 13(1):46-50. PubMed ID: 17212724
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of acquired hemophilia with oral immunosuppressive therapy.
    Shaffer LG, Phillips MD.
    Ann Intern Med; 1997 Aug 01; 127(3):206-9. PubMed ID: 9245226
    [Abstract] [Full Text] [Related]

  • 9. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V, Grgurević I, Kusec R, Gaćina P.
    Croat Med J; 2004 Apr 01; 45(2):213-6. PubMed ID: 15103761
    [Abstract] [Full Text] [Related]

  • 10. [Acquired inhibition of coagulation factor VIII].
    Figueroa H, Lira P, Grebe G, Mezzano D, Legues ME.
    Rev Med Chil; 1984 Jan 01; 112(1):43-6. PubMed ID: 6429807
    [No Abstract] [Full Text] [Related]

  • 11. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
    Petrovic M, Derom E, Baele G.
    Haematologica; 2000 Aug 01; 85(8):895-6. PubMed ID: 10942956
    [No Abstract] [Full Text] [Related]

  • 12. Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A.
    Eisert S, Mosler K, Laws HJ, Göbel U.
    Thromb Haemost; 2005 Apr 01; 93(4):792-3. PubMed ID: 15841330
    [No Abstract] [Full Text] [Related]

  • 13. Solid tumors and factor VIII antibodies.
    Hauser I, Lechner K.
    Thromb Haemost; 1999 Sep 01; 82(3):1005-7. PubMed ID: 10494753
    [Abstract] [Full Text] [Related]

  • 14. [Refractory acquired hemophilia A successfully treated with CVP].
    Kaneko H, Okada N, Matsui Y, Nishizawa M, Watanabe M, Miura Y, Tsudo M.
    Rinsho Ketsueki; 2009 Feb 01; 50(2):110-2. PubMed ID: 19265305
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of factor VIII versus nonspecific inhibitors.
    Goldsmith JC.
    Semin Hematol; 1993 Apr 01; 30(2 Suppl 1):3-6. PubMed ID: 8480195
    [No Abstract] [Full Text] [Related]

  • 16. Factor VIII inhibitors--an algorithmic approach to treatment.
    Kessler CM.
    Semin Hematol; 1994 Apr 01; 31(2 Suppl 4):33-6. PubMed ID: 7939771
    [No Abstract] [Full Text] [Related]

  • 17. A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor.
    Gandini G, Franchini M, Manzato F, Lippi G, Aprili G.
    Haematologica; 1999 Nov 01; 84(11):1054. PubMed ID: 10553173
    [No Abstract] [Full Text] [Related]

  • 18. [Acquired factor VIIIc inhibitors. Two cases and a review of the literature].
    Bayani N, Lelong F.
    Ann Med Interne (Paris); 2001 Apr 01; 152(3):201-8. PubMed ID: 11431582
    [No Abstract] [Full Text] [Related]

  • 19. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW, Saidi P, Philipp C.
    Haemophilia; 2004 Nov 01; 10(6):713-21. PubMed ID: 15569166
    [Abstract] [Full Text] [Related]

  • 20. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L, Pitlik E.
    Haematologica; 2000 Oct 01; 85(10 Suppl):64-8. PubMed ID: 11187874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.